Latest trends in Ready To Use packaging for more flexible use of filling lines and lower TCO
Ready-to-use syringes have long been a staple of the pharmaceutical industry. They are pre-sterilized and packed in nests and tubs, simplifying the filling process as they relieve pharmaceutical manufacturers from performing the pre-treating steps of depyrogenation, washing and sterilization.
Now the same concepts are being applied to other packaging categories, such as vials. Since based on proven nest-and-tub standards, this enables pharma companies to process different types of packaging on the same production lines and without long set-up times. This way, even smaller batches can be filled very efficiently.
With new markets emerging and rising regulatory pressure more and more pharma companies are showing interest in these flexible filling concepts. They want to react quicker to market trends without having to build up large scale manufacturing capacities. Up to now, however, ready to use systems require the vials to be handled in bulk for certain process steps, such as freeze drying or closure, with possible negative impact on quality.
In this webinar you will learn about the latest ready-to-use filling solution for vials and which aspects need to be considered when selecting a suitable system. A model calculation will show effects on the TCO (total cost of ownership). We will also reveal the results of a feasibility study, showing how nested vials pass through the freeze-drying process and how the results differ from bulk vials.
This webinar is essential for every pharma company searching for flexible filling concepts or different ingredients/packaging configurations to be filled more efficiently.
Presented by
Gregor Deutschle,
Global Product Manager SCHOTT Pharmaceutical Packaging
As global product manager Gregor is responsible for SCHOTT's sterile vials and cartridges product lines. He focuses on aseptic filling and works closely with filling line manufacturers and lead customers to develop new packaging solutions. Gregor joined the company seven years ago and has been working at SCHOTT's Pharmaceutical Systems Business Unit since 2012. He holds a degree in mechanical engineering.
